Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Using a highly abbreviated California Verbal Learning Test-II to detect verbal memory deficits.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study.
The histaminergic network in the brain: basic organization and role in disease.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
FDA approves first oral drug to reduce MS relapses
Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis.
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Simvastatin in acute optic neuritis.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.

Pages